Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) Short Interest Down 73.5% in December

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) was the target of a significant decrease in short interest in December. As of December 31st, there was short interest totalling 3,500 shares, a decrease of 73.5% from the December 15th total of 13,200 shares. Based on an average daily volume of 33,700 shares, the days-to-cover ratio is presently 0.1 days.

Reviva Pharmaceuticals Stock Performance

Shares of RVPHW stock traded down $0.09 during trading on Tuesday, hitting $0.24. 65,170 shares of the company were exchanged, compared to its average volume of 54,309. The business’s 50-day simple moving average is $0.21 and its 200 day simple moving average is $0.17. Reviva Pharmaceuticals has a twelve month low of $0.07 and a twelve month high of $1.20.

About Reviva Pharmaceuticals

Reviva Pharmaceuticals Holdings, Inc, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for use in the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis.